An effective drug for Alzheimer's disease is on the horizon, The Telegraph website reports today (July 5, 2023).
U.S. scientists announced that the drug donanemab delays worsening of symptoms by 35%.
Half of the patients on the trial found their mental decline was halted for more than a year.
No comments:
Post a Comment